CLIFTON ALLRED: Open Payments
NPI 1265030175 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 21 payments from 11 companies in 2025. Trend: 2023 $939 · 2024 $363 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| IDORSIA PHARMACEUTICALS US INC | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: Quviviq, REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, Auvelity, INVEGA SUSTENNA, INGREZZA.
Industry payments across TN — which companies pay providers there.
